Cell Works Group, Inc.

Cell Works Group, Inc.

Cell Works Group, Inc.

Overview
Date Founded

2005

Headquarters

2033 Gateway Place,Suite 500,San Jose, CA 95110

Type of Company

Private

Employees (Worldwide)

51 - 100

Industries

Other Business & Consulting Services
Appliances & Electronics
Computer Software
Pharmaceuticals
Holding Companies

Company Description

Cell Works Group, Inc. engages in designing therapeutics with engineering precision. It also offers drug development and recycling and repurposing services. The company was founded by Shireen Vali, Pradeep Fernandes and Taher Abbasi in June 2005 and is headquartered in San Jose, CA.

Executives & Employees

Co-Founder

Co-Founder

Chief Executive Officer & Director

Chief Technical Officer

Chief Medical Officer

Head of Science, Bugworks

Group Leader, Clinical Translation Sciences

Board of Directors

Venture Partner at Physic Ventures LLC

Co-Founder at Ventria Bioscience, Inc.

Chief Executive Officer & Director at Cell Works Group, Inc.

Co-Founder at Cell Works Group, Inc.

Chairman at Northgate Capital LLC

Former Chief Medical Officer at Vivius, Inc.

Chief Executive Officer at Conquer Cancer Foundation

Co-Founder at Cell Works Group, Inc.

Paths to Cell Works Group, Inc.
Potential Connections via
Relationship Science
You
Cell Works Group, Inc.
Recent Transactions
Details Hidden

Cell Works Group, Inc. raised money in a private placement transaction

Details Hidden

Cell Works Group, Inc. raised money in a private placement transaction

Details Hidden

Cell Works Group, Inc. raised money in a private placement transaction

Investors
Details Hidden

Sequoia Capital invests in seed to early stage companies. The firm focuses on energy, financial services, healthcare, Internet, mobile and technology sectors. Within the energy sector, the firm seeks to partner with start-ups focused on the alternative energy, conventional energy, energy efficiency, energy storage and energy services markets.

Details Hidden

Artiman Ventures makes early-stage investments in the commercialization of leading-edge technologies. Their technology-diversified investment strategy focuses on opportunities where a company has no identifiable competitors and has a market or technology lead of at least twelve months. Artiman typically serves as the first institutional investor, investing at the concept stage when the founders are still refining their key ideas and concepts. The firm's initial investments range in size from $100,000 in seed funding to a conventional Series A investment of $2 million to $4 million. They prefer to limit aggregate investment over the life of a company to approximately $10 million.

Details Hidden

Co-Founder at Cell Works Group, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cell Works Group, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cell Works Group, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cell Works Group, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/cell-works-group-inc-166673
  • https://relationshipscience.com/organization/cell-works-group-inc-166673